350 related articles for article (PubMed ID: 35052776)
1. Nanomedicine in Clinical Photodynamic Therapy for the Treatment of Brain Tumors.
Kim HS; Lee DY
Biomedicines; 2022 Jan; 10(1):. PubMed ID: 35052776
[TBL] [Abstract][Full Text] [Related]
2. Dual-selective photodynamic therapy with a mitochondria-targeted photosensitizer and fiber optic cannula for malignant brain tumors.
Kang JH; Ko YT
Biomater Sci; 2019 Jul; 7(7):2812-2825. PubMed ID: 31066391
[TBL] [Abstract][Full Text] [Related]
3. Nanomedicine associated with photodynamic therapy for glioblastoma treatment.
de Paula LB; Primo FL; Tedesco AC
Biophys Rev; 2017 Oct; 9(5):761-773. PubMed ID: 28823025
[TBL] [Abstract][Full Text] [Related]
4. Brain endothelial cell-derived extracellular vesicles with a mitochondria-targeting photosensitizer effectively treat glioblastoma by hijacking the blood‒brain barrier.
Nguyen Cao TG; Kang JH; Kang SJ; Truong Hoang Q; Kang HC; Rhee WJ; Zhang YS; Ko YT; Shim MS
Acta Pharm Sin B; 2023 Sep; 13(9):3834-3848. PubMed ID: 37719366
[TBL] [Abstract][Full Text] [Related]
5. Nanotherapeutic Intervention in Photodynamic Therapy for Cancer.
Itoo AM; Paul M; Padaga SG; Ghosh B; Biswas S
ACS Omega; 2022 Dec; 7(50):45882-45909. PubMed ID: 36570217
[TBL] [Abstract][Full Text] [Related]
6. Photodynamic Therapy for Glioblastoma: Illuminating the Path toward Clinical Applicability.
Bhanja D; Wilding H; Baroz A; Trifoi M; Shenoy G; Slagle-Webb B; Hayes D; Soudagar Y; Connor J; Mansouri A
Cancers (Basel); 2023 Jun; 15(13):. PubMed ID: 37444537
[TBL] [Abstract][Full Text] [Related]
7. Photodynamic therapy of Glioblastoma cells using doped conjugated polymer nanoparticles: An in vitro comparative study based on redox status.
Caverzán MD; Beaugé L; Chesta CA; Palacios RE; Ibarra LE
J Photochem Photobiol B; 2020 Nov; 212():112045. PubMed ID: 33022469
[TBL] [Abstract][Full Text] [Related]
8. Reactive oxidative species (ROS)-based nanomedicine for BBB crossing and glioma treatment: current status and future directions.
Wu D; Chen X; Zhou S; Li B
Front Immunol; 2023; 14():1241791. PubMed ID: 37731484
[TBL] [Abstract][Full Text] [Related]
9. Targeted Delivery of Functionalized Upconversion Nanoparticles for Externally Triggered Photothermal/Photodynamic Therapies of Brain Glioblastoma.
Tsai YC; Vijayaraghavan P; Chiang WH; Chen HH; Liu TI; Shen MY; Omoto A; Kamimura M; Soga K; Chiu HC
Theranostics; 2018; 8(5):1435-1448. PubMed ID: 29507632
[TBL] [Abstract][Full Text] [Related]
10. Progress in Clinical Trials of Photodynamic Therapy for Solid Tumors and the Role of Nanomedicine.
Alsaab HO; Alghamdi MS; Alotaibi AS; Alzhrani R; Alwuthaynani F; Althobaiti YS; Almalki AH; Sau S; Iyer AK
Cancers (Basel); 2020 Sep; 12(10):. PubMed ID: 33003374
[TBL] [Abstract][Full Text] [Related]
11. Using Light for Therapy of Glioblastoma Multiforme (GBM).
Vasilev A; Sofi R; Rahman R; Smith SJ; Teschemacher AG; Kasparov S
Brain Sci; 2020 Jan; 10(2):. PubMed ID: 32024010
[No Abstract] [Full Text] [Related]
12. Understanding the glioblastoma tumor biology to optimize photodynamic therapy: From molecular to cellular events.
Ibarra LE; Vilchez ML; Caverzán MD; Milla Sanabria LN
J Neurosci Res; 2021 Apr; 99(4):1024-1047. PubMed ID: 33370846
[TBL] [Abstract][Full Text] [Related]
13. Photodynamic process induced by chloro-aluminum phthalocyanine nanoemulsion in glioblastoma.
Castilho-Fernandes A; Lopes TG; Primo FL; Pinto MR; Tedesco AC
Photodiagnosis Photodyn Ther; 2017 Sep; 19():221-228. PubMed ID: 28599959
[TBL] [Abstract][Full Text] [Related]
14. Nanotechnology meets glioblastoma multiforme: Emerging therapeutic strategies.
Liu D; Dai X; Ye L; Wang H; Qian H; Cheng H; Wang X
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2023 Jan; 15(1):e1838. PubMed ID: 35959642
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of Resistance and Current Treatment Options for Glioblastoma Multiforme (GBM).
Yalamarty SSK; Filipczak N; Li X; Subhan MA; Parveen F; Ataide JA; Rajmalani BA; Torchilin VP
Cancers (Basel); 2023 Apr; 15(7):. PubMed ID: 37046777
[TBL] [Abstract][Full Text] [Related]
16. Bioactivatable reactive oxygen species-sensitive nanoparticulate system for chemo-photodynamic therapy.
Kim Y; Uthaman S; Pillarisetti S; Noh K; Huh KM; Park IK
Acta Biomater; 2020 May; 108():273-284. PubMed ID: 32205212
[TBL] [Abstract][Full Text] [Related]
17. Physiological oxygen concentration alters glioma cell malignancy and responsiveness to photodynamic therapy in vitro.
Albert I; Hefti M; Luginbuehl V
Neurol Res; 2014 Nov; 36(11):1001-10. PubMed ID: 24923209
[TBL] [Abstract][Full Text] [Related]
18. Interstitial Photodynamic Therapy for Glioblastomas: A Standardized Procedure for Clinical Use.
Leroy HA; Baert G; Guerin L; Delhem N; Mordon S; Reyns N; Vignion-Dewalle AS
Cancers (Basel); 2021 Nov; 13(22):. PubMed ID: 34830908
[TBL] [Abstract][Full Text] [Related]
19. Harnessing nanomedicine for therapeutic intervention in glioblastoma.
Gutkin A; Cohen ZR; Peer D
Expert Opin Drug Deliv; 2016 Nov; 13(11):1573-1582. PubMed ID: 27292970
[TBL] [Abstract][Full Text] [Related]
20. Targeted Photodynamic Diagnosis and Therapy for Esophageal Cancer: Potential Role of Functionalized Nanomedicine.
Didamson OC; Abrahamse H
Pharmaceutics; 2021 Nov; 13(11):. PubMed ID: 34834358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
